Submit your business proposal
日本語
About
Strategy
Team
Funds
Portfolio
News
Contact
Submit your business proposal
日本語
About
Strategy
Team
Funds
Portfolio
News
Contact
News
News type
Article
Event
Press release
Region
Japan
EU
Latest news
30th November 2023
Acticor Biotech completes a capital increase for a total gross amount of approximately 2.6 million euros, via the issuance of 850,360 shares
Read more
29th November 2023
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
Read more
19th October 2023
Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission
Read more
19th October 2023
Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome
Read more
20th September 2023
AbolerIS Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases
Read more
19th September 2023
Sequana Medical announces H1 2023 results and provides business update
Read more
19th September 2023
ACTICOR adapts its ACTISAVE clinical study to prepare the registration of glenzocimab for the treatment of stroke
Read more
19th September 2023
Ann Meulemans and AbolerIS Pharma is featured in De Tijd newspaper
Read more
5th September 2023
ACTIMIS post-hoc results on imaging stroke data using Artificial Intelligence reinforces glenzocimab mode of action in stroke patients
Read more
1
2
3
4
Sign up
You are added to the list, thank you!